Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Haagmans

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Developments in Biological Standardization|January 1, 1986
Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human useE C Beuvery, G J Speijers, B I Lutz, et al.
Immunology Letters|October 1, 1991
Pneumococcal conjugate vaccinesC C Peeters, A M Tenbergen-Meekes, B Haagmans, et al.
Journal of Hepatology|March 1, 2011
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CP-Y Bochud, S Bibert, F Negro, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 19, 2013
Specific serology for emerging human coronaviruses by protein microarrayC Reusken, H Mou, G J Godeke, et al.
Journal of Critical Care|November 17, 2023
Presence of procoagulant peripheral blood mononuclear cells in severe COVID-19 patients relate to ventilation perfusion mismatch and precede pulmonary embolismM Raadsen, T Langerak, J Du Toit, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Developments in Biological Standardization|January 1, 1986
Analytical, toxicological and immunological consequences of the use of N-ethyl-N'-(3-dimethylaminopropyl) carbodiimide as coupling reagent for the preparation of meningococcal group C polysaccharide-tetanus toxoid conjugate as vaccine for human useE C Beuvery, G J Speijers, B I Lutz, et al.
Immunology Letters|October 1, 1991
Pneumococcal conjugate vaccinesC C Peeters, A M Tenbergen-Meekes, B Haagmans, et al.
Journal of Hepatology|March 1, 2011
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CP-Y Bochud, S Bibert, F Negro, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 19, 2013
Specific serology for emerging human coronaviruses by protein microarrayC Reusken, H Mou, G J Godeke, et al.
Journal of Critical Care|November 17, 2023
Presence of procoagulant peripheral blood mononuclear cells in severe COVID-19 patients relate to ventilation perfusion mismatch and precede pulmonary embolismM Raadsen, T Langerak, J Du Toit, et al.
Pageof 1